alovudine has been researched along with Malignant Melanoma in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Barker, LW; Carvajal, RD; Dercle, L; Finkel, GG; Geskin, LJ; Rizk, EM; Saenger, YM; Schwartz, GK; Schwartz, L; Trager, MH; Yeh, R | 1 |
| Bomalaski, JS; Fuchs, S; Jungbluth, AA; Larson, SM; Longo, VA; Raschzok, N; Ritter, G; Sauer, IM; Stelter, L; Zanzonico, P | 1 |
| Algazi, AP; Bastian, BC; Behr, S; Cha, E; Chong, K; Coakley, F; Cortez, B; Daud, AI; Hwang, J; Liu, S; McCalmont, T; Ortiz-Urda, SM; Pampaloni, MH; Quiroz, A | 1 |
| Allen-Auerbach, MS; Benz, MR; Chmielowski, B; Czernin, J; Gomez-Navarro, J; McCarthy, T; Radu, C; Ribas, A; Seja, E; Williams, JL | 1 |
| Fukumura, T; Hasegawa, A; Inubushi, M; Kamada, T; Koizumi, M; Koto, M; Morikawa, T; Saga, T; Takagi, R; Tanimoto, K; Wakatuki, M; Yamada, S; Yoshikawa, K | 1 |
| Cobben, DC; Elsinga, PH; Hoekstra, HJ; Jager, PL; Maas, B; Suurmeijer, AJ | 1 |
3 trial(s) available for alovudine and Malignant Melanoma
| Article | Year |
|---|---|
The combination of axitinib followed by paclitaxel/carboplatin yields extended survival in advanced BRAF wild-type melanoma: results of a clinical/correlative prospective phase II clinical trial.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Axitinib; Carboplatin; Dideoxynucleosides; Female; Humans; Imidazoles; Indazoles; Male; Melanoma; Middle Aged; Paclitaxel; Positron-Emission Tomography; Prospective Studies; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Radiography; Treatment Outcome | 2015 |
Imaging of CTLA4 blockade-induced cell replication with (18)F-FLT PET in patients with advanced melanoma treated with tremelimumab.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antigens, CD; Cell Proliferation; CTLA-4 Antigen; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Spleen; Tomography, X-Ray Computed; Tumor Burden | 2010 |
Predictive value of 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography/computed tomography for outcome of carbon ion radiotherapy in patients with head and neck mucosal malignant melanoma.
Topics: Aged; Aged, 80 and over; Dideoxynucleosides; Female; Follow-Up Studies; Head and Neck Neoplasms; Heavy Ion Radiotherapy; Humans; Male; Melanoma; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2013 |
3 other study(ies) available for alovudine and Malignant Melanoma
| Article | Year |
|---|---|
FLT-PET At 6 Weeks Predicts Response Assessed by CT at 12 Weeks in Melanoma Patients Treated With Pembrolizumab.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Dideoxynucleosides; Female; Humans; Male; Melanoma; Middle Aged; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tumor Burden | 2020 |
Evaluation of arginine deiminase treatment in melanoma xenografts using (18)F-FLT PET.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Dideoxynucleosides; Hydrolases; Immunohistochemistry; Ki-67 Antigen; Melanoma; Mice; Signal Transduction; Thymidine Kinase; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2013 |
3'-18F-fluoro-3'-deoxy-L-thymidine: a new tracer for staging metastatic melanoma?
Topics: Adult; Aged; Bone Marrow Neoplasms; Dideoxynucleosides; False Negative Reactions; False Positive Reactions; Feasibility Studies; Female; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Skin Neoplasms; Tomography, Emission-Computed | 2003 |